Rituximab as first line treatment for MALT lymphoma of extraocular muscles (Journal article)

Benetatos, L./ Alymara, V./ Asproudis, I./ Bourantas, K. L.

Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Antibodies, Monoclonal/*administration & dosage,Antibodies, Monoclonal, Murine-Derived,Antineoplastic Agents/*administration & dosage,Humans,Lymphoma, B-Cell, Marginal Zone/*drug therapy/pathology,Male,Middle Aged,Muscle Neoplasms/*drug therapy/pathology,*Oculomotor Muscles/pathology,Remission Induction,Stomach Neoplasms/drug therapy/pathology,Time Factors
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/18537
ISSN: 0939-5555
Link: http://www.ncbi.nlm.nih.gov/pubmed/16691396
http://www.springerlink.com/content/f3t8784117343k47/fulltext.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Benetatos-2006-Rituximab as first l.pdf72.11 kBAdobe PDFView/Open    Request a copy


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18537
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.